RPG Life Sciences share price
You have to be logged in to add this to Watchlist.- ₹2,228.80(1.27%)December 5, 2025 15:29:10 PM IST
- NSE
- BSE
- Vol : 4.61 K (NSE + BSE)Last 20 day avg : 14.67 K
RPG Life Sciences is trading 1.27% upper at Rs 2,228.80 as compared to its last closing price. RPG Life Sciences has been trading in the price range of 2,228.80 & 2,196.50. RPG Life Sciences has given 1.26% in this year & -0.98% in the last 5 days. RPG Life Sciences has TTM P/E ratio 17.15 as compared to the sector P/E of 32.51.The company posted a net profit of 36.85 Crores in its last quarter.Listed peers of RPG Life Sciences include Dr Reddy's Laboratories (-0.04%), Sun Pharmaceutical Industries (-0.75%), Torrent Pharmaceuticals (-0.74%).The Mutual Fund holding in RPG Life Sciences was at 3.20% in 30 Sep 2025. The MF holding has decreased from the last quarter. The FII holding in RPG Life Sciences was at 1.11% in 30 Sep 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Dec 06, 2025, 10:16 AM UTC
- BetaLow volatility0.55Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.00The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldInline with the industry0.91Annual dividends as a percentage of the stock price.
- P/BHigher than historical values6.88The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values16.95Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation0.32The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Dr Reddy's Laboratories | Bullish | 1,276.55 | -0.04 | 1,06,330.42 | 18.80 | 3.17 | 0.63 | 2.34 |
| Sun Pharmaceutical Industries | Bullish | 1,805.00 | -0.75 | 4,33,140.85 | 37.94 | 6.04 | 0.88 | 0.50 |
| Torrent Pharmaceuticals | Bullish | 3,773.70 | -0.74 | 1,27,661.97 | 66.64 | 16.92 | 0.84 | 17.62 |
| Cipla | Neutral | 1,520.55 | -0.04 | 1,22,825.65 | 23.33 | 3.94 | 0.85 | 0.81 |
| Divi's Laboratories | Bullish | 6,468.25 | -0.04 | 1,73,113.62 | 78.27 | 11.47 | 0.46 | 0.01 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-10-17 | Quarterly Results |
| 2025-07-25 | Quarterly Results |
| 2025-04-28 | Audited Results & Final Dividend |
| 2025-01-24 | Quarterly Results |
| 2024-11-07 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE105J01010
- BSE Code532983
- NSE CodeRPGLIFE
RPG Life Sciences is trading at 2228.80 as on Fri Dec 05 2025 09:59:10. This is 1.27% upper as compared to its previous closing price of 2200.75.
The market capitalization of RPG Life Sciences is 3679.11 Cr as on Fri Dec 05 2025 09:59:10.
The 52 wk high for RPG Life Sciences is 2715.90 whereas the 52 wk low is 1769.13
RPG Life Sciences can be analyzed on the following key metrics -
- TTM P/E: 17.15
- Sector P/E: 32.51
- Dividend Yield: 0.91%
- D/E ratio: 0.00
RPG Life Sciences reported a net profit of 183.24 Cr in 2025.
The Mutual Fund Shareholding was 3.20% at the end of 30 Sep 2025.
EQUITY QUICK LINKS
RPG Life Sciences QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.